InterTabac 2025 Insights｜BAT Exhibits Full Portfolio, Highlights VUSE Ultra and Introduces Zero-Nicotine Products

Sep.19

2Firsts’ on-site reporting at InterTabac 2025 in Dortmund, Germany, found that BAT showcased a range of HTP, e-vapor, and nicotine pouch products, with a focus on zero-nicotine e-vapor and the VUSE Ultra line, and set up an interactive experience area.

2Firsts, September 18, 2025, Dortmund, Germany — InterTabac 2025 is being held from September 18 to 20 in Dortmund. During the exhibition, 2Firsts visited the halls and observed that British American Tobacco (BAT) exhibited multiple products, including the glo heated tobacco (HTP) brand, the VUSE e-vapor brand, and the VELO nicotine pouch brand.

E-vapor: VUSE Ultra as the Flagship, New Zero-Nicotine Product

At this year’s show, BAT’s core push is its new e-vapor product, VUSE Ultra. Large-format advertising was deployed on site, and a dedicated zone was set up for display.（Read More：

Notably, BAT also brought the zero-nicotine product VUSE GO 1000. It features a replaceable-pod design, with two pods included in each kit.

Heated Tobacco: Focus on glo HYPER PRO

Nicotine Pouches

Interactive Booth Area

For more on-the-ground coverage, visit the2Firsts InterTabac Special Section.

Also Read:

[1] Inter Tabac 2025: 2Firsts Provides Exclusive Coverage of New Tobacco Products and Industry Trends

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer

Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.

Nov.26

Altria Director George Muñoz to Retire After 2026 Shareholder Meeting;

Altria director George Muñoz plans to retire post-2026 annual meeting, not seeking re-election. Annual meeting expected on May 14.

Oct.15 by 2FIRSTS.ai

Luxembourg Passes Bill 8333: Heated Tobacco and Nicotine Pouches Regulated

Luxembourg’s Chamber of Deputies adopted Bill No. 8333, transposing EU Directive 2022/2100 and extending tobacco controls to heated tobacco, e-cigarettes and nicotine pouches. The law bans flavourings, restricts sales to minors, and caps nicotine content at 0.048 mg per pouch. CBD and caffeine additives are prohibited.

Nov.03 by 2FIRSTS.ai

FDA Calls on Retailers to Remove Illegal E-Cigarettes from Shelves, Will Send List of Legal Products to 300,000 Stores

FDA launches national retail compliance initiative to combat illegal e-cigarette sales targeting youth, issuing guidance materials to over 300k retailers.